Biogen Statement about Director Lynn Schenk
We are thankful for the service of Lynn Schenk as a director of IDEC since 1995 and then a director of the merged Biogen company since 2004. Lynn will retire from the Biogen Board at the end of her current term, which expires at the 2020 annual meeting of stockholders.
Biogen Statement: Business Update Regarding COVID-19
The current COVID-19 pandemic has presented a substantial public health and economic challenge around the world. As governments, businesses and other organizations take unprecedented measures to help mitigate the spread of the outbreak, we want to reinforce our deep commitment to our employees, our